# title
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.

# relatedArtifact[].display
Joel M. Neutel et al. The Journal of Clinical Hypertension (Wiley), 04 / 2004

# relatedArtifact[].document.title
Use of an Olmesartan Medoxomil‐Based Treatment Algorithm for Hypertension Control

# variableDefinition[].description
Efficacy is calculated as the number of people who had a specific benefit from the treatment divided by the number of people who used or underwent the treatment. The specific benefits are categorized as the code system below.

# statistic[].description
Efficacy calculated based on patients who achieved a persistent reduction in the intensity, frequency, or variety of symptoms with the use of the treatment.